Pharmaceutical composition, excipient for the composition and use of the composition
A pharmaceutical composition containing synthetic Cannabidiol and its use in obtaining a medication for the treatment of neurological disorders, as well as the main excipients used in the production process, in addition to its small, medium, and large-scale preparation process. The use of the composition for the treatment of neurological disorders in human or animal populations, in particular in the treatment of Parkinson's disease, in the range of 300 to 850 mg/day or at daily doses of 100 to 1750 mg for neuroprotective action.
1. A method for neuroprotective action comprising the administration to a human or an animal of a pharmaceutical composition comprising Cannabidiol of synthetic origin, wherein said composition comprises up to 0.06% Cannabinol, up to 0.06% Delta-8-tetrahydrocannabinol, up to 0.06% Delta-9-tetrahydrocannabinol, up to 0.06% Cannabidiolic acid methyl ester, up to 0.06% Menthadienol, and up to 0.06% Methyl olivetolate.
2. The method of treatment according to claim 1 , wherein the administration is at the dose of 100 to 1750 mg/day.
3. The method according to claim 2 , wherein the dose is a single dose or doses divided throughout the day.
4. The method according to claim 1 , wherein the neuroprotective action is for neurological disorders selected from the group consisting of refractory epilepsy, epilepsy, schizophrenia, sleep disorders, post-traumatic disorder, Alzheimer's disease, anxiety, depression, bipolar disorder, neuropathic pain, chronic pain relief, autism, chronic pain relief, and Parkinson's disease.